Evolus (EOLS) Net Margin (2019 - 2026)
Evolus (EOLS) posted Net Margin of -9.58% for Q2 2026, up 15.13 percentage points from -24.70% a year earlier and up 5.02 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Net Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Evolus was -10.85%, up 11.46 percentage points year-over-year; for FY2025, it was -17.38%, up 1.56 percentage points from FY2024.
- Annual Net Margin has increased for three consecutive years, with a five-year change of +270.94 percentage points (FY2020 to FY2025).
- In prior years, Evolus' Net Margin was -18.94% in FY2024 (+11.59 pp), -30.52% in FY2023 (+19.55 pp), -50.07% in FY2022 (-3.11 pp) and -46.96% in FY2021 (+241.35 pp).
- Quarterly Net Margin has run from a low of -72.85% in Q3 2021 to a high of 0.14% in Q4 2025 over five years.
- On a year-over-year basis, Net Margin has increased in each of the last four quarters, with an average year-over-year change of +5.68 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 485.50 percentage points; the weakest was Q1 2022, with a drop of 103.90 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -14.59% (Q1 2026), 0.14% (Q4 2025) and -22.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Evolus | 525.47 Mn | 333.16 Mn | 57.18 Mn | -9.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.58% |
| Mar 31, 2026 | -14.59% |
| Dec 31, 2025 | 0.14% |
| Sep 30, 2025 | -22.82% |
| Jun 30, 2025 | -24.70% |
| Mar 31, 2025 | -27.57% |
| Dec 31, 2024 | -8.60% |
| Sep 30, 2024 | -31.38% |
| Jun 30, 2024 | -16.96% |
| Mar 31, 2024 | -22.09% |
| Dec 31, 2023 | -19.40% |
| Sep 30, 2023 | -33.83% |
| Jun 30, 2023 | -36.76% |
| Mar 31, 2023 | -35.45% |
| Dec 31, 2022 | -30.16% |
| Sep 30, 2022 | -59.81% |
| Jun 30, 2022 | -63.16% |
| Mar 31, 2022 | -51.61% |
| Dec 31, 2021 | -52.45% |
| Sep 30, 2021 | -72.85% |
API Access
Evolus Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();